Microporation Technology Enabling Through-the-skin Therapeutics and Diagnostics

New Report by Applied Data Research Analyzes Technology and Commercial Factors

[ClickPress, Mon Apr 02 2007] Microporation technology is attaining commercial viability at a time when medical device designers and drug developers are faced with new challenges as they assess ways to address therapeutic and diagnostic needs that are patient-friendly and cost-effective. The widespread availability of rapid throughput screening is accelerating the discovery of large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration.

Evolving microporation systems will be well-positioned to address a significant segment of the large–molecule biological drugs expected to emerge from the convergence of automated discovery and genome mapping. Recent studies suggesting that patients suffering from chronic conditions such as insulin-dependent (Type I) diabetes and cardiovascular disease can benefit from more frequent blood analyte monitoring is driving a push for improved self-testing and even continuous monitoring systems. Microporation is being used as the core of through-the-skin devices to sample analytes of interest in the interstitial fluid.

These findings are contained in a new and comprehensive report – Microporation: Drug Delivery and Medical Diagnostic Opportunities. The report has been carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors.

More information is available at www.applieddata.org .


About Applied Data

Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis.

Contact:

Greg Stone
Voice: 603-595-6225
Fax: 603-804-0466
www.applieddata.org Source: Applied Data Research

Bookmark this release: Del.icio.us - Digg - Furl - Blinklist - Reddit